AG
MD icon

Advisor Group’s Pediatrix Medical MD Stock Holding History

Advisor Group’s Portfolio MD Stock Details MD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$66K Buy
2,429
+1,390
+134% +$34.9K ﹤0.01% 3228
2019
Q3 		$23K Buy
1,039
+90
+9% +$2.05K ﹤0.01% 3867
2019
Q2 		$23K Sell
949
-311
-25% -$8.35K ﹤0.01% 3898
2019
Q1 		$34K Sell
1,260
-1,162
-48% -$39K ﹤0.01% 3647
2018
Q4 		$80K Sell
2,422
-13,926
-85% -$560K ﹤0.01% 2829
2018
Q3 		$763K Buy
16,348
+5,634
+53% +$259K 0.01% 1165
2018
Q2 		$464K Sell
10,714
-399
-4% -$19.1K 0.01% 1357
2018
Q1 		$618K Sell
11,113
-1,614
-13% -$88.5K 0.01% 1165
2017
Q4 		$680K Buy
12,727
+4,366
+52% +$206K 0.01% 1125
2017
Q3 		$359K Buy
8,361
+2,468
+42% +$117K 0.01% 1406
2017
Q2 		$356K Sell
5,893
-1,500
-20% -$88.9K 0.01% 1360
2017
Q1 		$512K Buy
7,393
+258
+4% +$17.9K 0.01% 1061
2016
Q4 		$475K Sell
7,135
-48
-0.7% -$3.12K 0.01% 1047
2016
Q3 		$475K Buy
7,183
+185
+3% +$12.7K 0.01% 999
2016
Q2 		$505K Buy
+6,998
New +$481K 0.01% 915

Other funds holding MD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
PCP
P2 Capital Partners New York $210M AUM 1.23% 1-Year Est. Return
SV
Starboard Value New York $4.57B AUM 4.97% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Advisor Group's MD Position: Q4 2019 in Review

Advisor Group increased its Pediatrix Medical (MD) stake by 134% in Q4 2019, buying an estimated $34.9K and bringing the position to 2,429 shares worth $66K. The position accounts for ﹤0.01% of the portfolio, ranked #3228.

Advisor Group first reported a position in MD in Q2 2016 and has held it in 15 quarters since. The position peaked at $763K in Q3 2018. 258 funds tracked by Wall St. Rank hold MD as of Q4 2019.

  • Advisor Group held 2,429 shares of Pediatrix Medical worth $66K as of Q4 2019.
  • Advisor Group bought 1,390 Pediatrix Medical shares in Q4 2019, an estimated $34.9K.
  • Pediatrix Medical made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #3228 holding.
  • Advisor Group first reported a position in Pediatrix Medical in Q2 2016 and has held it in 15 quarters since.
  • Advisor Group's Pediatrix Medical position peaked at $763K in Q3 2018.
  • 258 funds tracked by Wall St. Rank held Pediatrix Medical as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.